Notably, GLIPR2’s prognostic relevance is histotype-specific, exhibiting significance in LUAD but not in LUSC, indicative of distinct molecular pathways governing these NSCLC subtypes. This evidence concerns the gene GLIPR2 and non-small cell lung carcinoma.